Hormones of the pituitary control the major biological functions of stress, growth, metabolism and reproduction. In animals these hormones show pronounced seasonality, with different set points for different seasons. In humans, the seasonality of these hormones has rarely been studied in a large enough dataset to discern common patterns. Here, we analyze an Israeli health record on 46 million person-years, including millions of hormone blood tests. We find clear seasonal patterns: the pituitary hormones peak in summer, whereas their downstream effector hormones are in anti-phase, and peak in winter-spring. This anti-phase is unexpected because the pituitary hormones control the downstream hormones. We show that the antiphase can arise from changes in the mass of the glands due to trophic effects of the hormones, generating a feedback circuit with a natural frequency of about a year that can entrain to the seasons. Thus, humans may show coordinated seasonal set-points with a winter-spring peak in the growth, stress adaptation, metabolism and reproduction axes.
Introduction
The pituitary hormones control major biological functions in mammals, including growth, reproduction, metabolism and stress adaptation. Each of these functions has a dedicated hormonal axis, in which signals from the hypothalamus cause secretion of the pituitary hormone into the bloodstream. The pituitary hormone instructs a peripheral organ to secrete effector hormones with widespread effects on many tissues. For example, stress response is governed by the hypothalamic-pituitary-adrenal (HPA) axis: physiological and psychological stress signals cause the hypothalamus to induce secretion of ACTH from the pituitary, which instructs the adrenal cortex to secrete cortisol. These axes act to maintain physiological setpoints, which can change in different situations, a concept known as allostasis (McEwen, 1998) . A major reason that organisms change their setpoints is the seasons. Animals show seasonal changes in the pituitary and effector hormones that govern seasonality in reproduction, activity, growth, pigmentation, morphology and migration (Gwinner, 2012) . Animals even show these changes with a circannual rhythm when maintained in constant photoperiod and temperature conditions (Zucker, 2001; Lincoln et al., 2006; Gwinner, 2012) . The fact that hormones can cycle without external signals suggests an internal oscillator with a period of about one year. The location of this oscillator is unclear, with some evidence of an involvement of melatonin signals to the pars tuberalis of the pituitary (Wood et al., 2015; Wood and Loudon, 2018) . Whether hormones show seasonality in humans has not been studied comprehensively by tracking all hormone in a large number of participants. Each axis has been studied separately, usually with small samples. These studies suggest that thyroid hormones and saliva cortisol show seasonality on the order of 10%. The studies are limited by considerations of circadian rhythms which affects cortisol and several other hormones. To study human hormone seasonality requires a large dataset with a comprehensive coverage of all hormones. Here we provide such as study using an Israeli medical record database with millions of blood tests. We address the circadian rhythm concern using the time of each test. We find coordinated seasonality with a spring peak in effector hormones and a surprising antiphase between pituitary and effector hormones. We provide an explanation for this antiphase by showing that trophic effects of the hormones create an oscillatory circuit in which the functional mass of the glands changes over the year and can entrain to yearly signals. The results support a winter-spring peak for human reproduction, metabolism, growth and stress adaptation.
Results

Data on millions of blood tests shows seasonality
We analyzed electronic medical record data from a large Israeli medical insurer (Clalit), which includes millions of blood tests (Fig 1) . The dataset includes about half of the Israeli population over 15 years (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) totaling 46 million life-years, with broad socioeconomic and ethnic representation. Electronic medical records have the challenge of ascertainment bias, because the tests are done for medical reasons. To address this, for each blood test we removed data from pregnant women, individuals with medical conditions that affect the blood test, and individuals that take drugs that affect the blood test (Methods). We considered male and females separately and binned age groups from 20-80 by decades (data for age range 20-50 is similar, SI). We performed quantile analysis in each decade to avoid age-related trends and outliers. Seasonality was assessed by cosinor tests (SI). One concern is hormone circadian rhythms, raising the question of the time of day the test was taken relative to the person's circadian cycle. To address this, we obtained the time of day of each test. The seasonality conclusions presented below are unaffected by considering only tests done at specific times of day, or by considering only tests done at a fixed time interval (2.5h) from dawn (SI). We also compared blood tests from one of the most circadian hormones, cortisol, to urine tests that gather cortisol over 24 hours, and find similar seasonality. We conclude that we can effectively control for circadian effects.
The data allowed us to consider all pituitary and effector hormones in a single framework. Hormones secreted by the anterior pituitary for reproduction (LH), metabolism (TSH), and lactation (PRL), showed seasonal oscillations that peak in summer, July or August. The pituitary stress hormone ACTH in females has much fewer tests but also shows a trend to a May-June peak, whereas data for males preclude identifying seasonality. The amplitude is on the order of 1-3 percentiles. This seasonality can be detected by virtue of the large number of tests. For example, TSH exceeds 6 million blood tests, resulting in error bars smaller than the dots in Fig The effector hormones, secreted from peripheral organs under control of the pituitary hormones, also showed seasonality with amplitudes of 1-6 percentiles. In contrast to the summer peak of the pituitary hormones, the effector hormone tests peaked in the winter or spring. The thyroid hormone T3 peaked in winter, in agreement with previous studies (Harrop & Hopton, 1985 , Maes et al., 1997 , consistent with its role in thermogeneration. Its precursor T4 peaked in late fall. The other effector hormones peaked in late-winter or spring, including the sex hormones testosterone, estradiol, progesterone and the growth hormone IGF1. For cortisol, both blood tests and 24-hour urine tests peaked in February. This late winter peak of cortisol is in agreement with previous studies, including large studies on saliva (Miller et al., 2016) and hair (Abell et al., 2016) cortisol from the UK, as well as smaller studies, including a similar winter peak shifted by 6 months in the southern hemisphere (Hadlow et al., 2014 (Hadlow et al., , 2018 . Several hormones showed a secondary peak, forming a biannual rhythm. To analyze this, we used a second-order cosinor model. TSH showed a major peak in august and a minor peak in winter, in agreement with a study on 1.5 million blood tests from Italy (Santi et al., 2009) . PRL test showed a similar biannual profile, perhaps due to the upstream regulator TRH that it shares with TSH (Friesen & Hwang, 1975) . The tests for the major sex effector hormones estradiol in females and testosterone in males both showed a biannual pattern with a secondary summer peak.
There are two exceptions to the rule that pituitary hormones peak in summer. The tests for pituitary growth hormone, GH, peak in spring, close to its downstream hormone IGF1. We note that like IGF1, GH also acts as an effector hormone, because it regulates growth and metabolism, unlike many other pituitary hormones which mainly have a regulatory role and are not effector hormones. The second exception is FSH in males that peaks in spring.
We also considered blood chemistry tests (ions, glucose, urea). These tests also showed seasonal oscillations with amplitudes on the order of 0.5-8 percentiles (SI). Their peak phases concentrated around Dec21 (shortest photoperiod) June 21 (longest photoperiod, SI). Full data is available in table S1. We conclude that there is a spring-delay for most of the effector hormone, shifting their peak from Dec 21 to later in the winter or to spring. Additional effector hormones including androgens also show a spring delay (SI). Furthermore, there is a phase shift between most of the effector hormones and their upstream pituitary hormone regulators, placing them in approximate anti-phase ( Fig 2B) . 
Phase shifts can be due to hormone-driven changes in gland masses
The spring-delay of effector hormones and the approximate antiphase between pituitary and effector hormones are puzzling, given the classical understanding of these axes. The classical model is that each pituitary hormone instructs the release of its effector hormones from peripheral glands and is in turn inhibited by the effector hormones by negative feedback loops ( Fig 3A) . Delays in these processes are on the order of minutes to days, and are negligible compared to the scale of months required to understand the spring-delay and antiphase. In contrast to the observed blood tests, the classical model predicts that pituitary hormones should coincide with their regulated hormones, and thus have the same seasonal phase as the effector hormones that they control (no antiphase). For hormones controlled by photoperiod, the peak should be at the time of extreme photoperiod (eg Dec21), Fig 3A. To understand the possible mechanism for the spring-delay and antiphase, we considered additional mechanisms that can provide a timescale of months. We focus on the HPA axis because it is well-studied in terms of molecular interactions (Chrousos, 1998) ; the other axes have analogous interactions (detailed in the SI). We find that a sufficient model for the observed phase shifts arises from adding to the classical model the effect of hormones as the primary growth factors of the tissues that they control ( Fig 3B) . These interactions are well characterized, but have not been considered on the systems level. In the HPA axis, ACTH not only causes the adrenal to secrete cortisol, it also increases the growth of the adrenal cells (Kataoka, Ikehara and Hattori, 1996; Bicknell et al., 2001) . Likewise, CRH not only causes corticotrophs in the pituitary to secrete ACTH, it also increases their growth rate (Westlund et al., 1985; Gertz et al., 1987; Nolan et al., 1998) . Thus, the total functional mass of the corticotrophs and adrenal cortex cells are timedependent variables. They change on the time-scale of weeks, as shown by experiments in rodents (Nolan, Thomas and Levy, 2004) , due to both hyperplasia and hypertrophy. The masses of the adrenal and pituitary are also known to change in humans, growing under prolonged stress or major depression and shrinking back when the stress or depression is relieved (Parker, Schatzberg and Lyons, 2003) . A similar idea, that seasonal clocks could arise from generation of tissue mass, was named by Lincoln et al the 'cyclic histogenic hypothesis' (Hazlerigg & Lincoln, 2011) We modeled the functional masses together with the classic hormone circuit (eq 1-5 in methods) (Karin et al., 2020) . On the timescale of weeks, the HPA axis acts as an oscillator in which the corticotroph and adrenal masses form a negative feedback loop ( Fig 3C) , with a typical timescale of a year (methods), that can entrain with seasonal input signals.
Simulations and analytical solutions (SI) show that the model entrains to a yearly seasonal input proportional to photoperiod, maximal in Dec 21, and minimal in Jun 21, providing seasonal oscillations to the hormones. The model provides the spring delay and the approximate antiphase: the effector hormone cortisol peaks in spring and the pituitary hormone ACTH peaks in late summer. The spring shift of cortisol and the antiphase between the hormones is caused by the time it takes the functional cell masses to grow and shrink. The spring delay and antiphase are found for a wide range of model parameters: the only parameters that affect the phases are the turnover times of the cell functional masses, which can range from a week to a few months and still provide the observed antiphase to within experimental error (SI). All other parameters such as hormone secretion rates and half-lives affect only the dynamics on the scale of hours, and do not measurably affect the seasonal phases. Similar interactions exist in the other pituitary axes (Plant, 2015; Ortiga-Carvalho et al., 2016) . Gland masses also dynamically change in these axes under control of the hormones. For example, thyroid proliferation is activated by the upstream hormone TSH, and thyroid volume changes in humans as exemplified by goiter (Dumont et al., 1992) . We provide models for each axis in the SI, finding that they are sufficient to explain the phases in each axis. The models can also explain why GH peaks in spring unlike the other pituitary hormones, due to the very slow turnover time of the peripheral gland in this axis, the liver. The models can also explain the fall peak of the thyroid hormone T4, based on the architecture of cell control in the thyroid axis. Alternative putative mechanisms with slow timescale, such as epigenetic mechanisms or seasonal parameter changes, are also considered in the SI.
Seasonality increases with latitude
The model predicts that the amplitude of seasonal variations should increase with latitude, due to greater photoperiod variation with the seasons. To test this we compared the model with studies from the UK (51 o N), Australia (30 o S) and Sweden (58 o N) on cortisol. The amplitude of cortisol seasonality rose with absolute latitude in agreement with the model predictions (SI) ( Fig 3F) . 
Pituitary volume shows seasonality
The functional mass model makes another testable prediction: the masses of the glands that secrete the hormones should vary with the seasons with specific phases. The total pituitary mass is made of several cell types, including somatotorphs that secrete GH, thyrotropes that secrete TSH, corticotrophs that secrete ACTH, gonadotrophs that secrete LH/FSH and lactotrophes that secrete PRL, as well as other factors including vasculature. Since we find that the pituitary hormones have similar phases (Fig 1) , we reasoned that one can consider total pituitary mass as a single variable. The model then predicts that the pituitary mass should peak in late spring, and thus be (perhaps surprisingly) out pf phase with the levels of the pituitary hormones that peak in late summer. This antiphase is due to the inhibition by the effector hormones -a prediction that is robust to model parameters. To test this, we analyzed a dataset of MRI brain scans and computed the volume of the pituitary. The model shows the same trend but misses by a season. ( Fig  3E) .
Discussion
We find that human hormone tests show a seasonal pattern with amplitudes on the order of a few percent. Most pituitary hormones peak in late summer, and effector hormones from downstream peripheral organs peak in winter/spring. The coordinated effector hormone peak suggests that winter/spring is a time of high setpoint for reproduction, metabolism, stress adaptation, and growth in humans. This relates favorably to observations on a winter-spring peak of human growth rate (Gelander, Karlberg & Albertsson, 1994; Land et al., 2005; Dalskov et al., 2016) , and sperm quality (De Giorgi et al., 2015; Levitas 2013) . Human fecundity also peaks in winter-spring in Israel and other countries in temperate clines (Roenneberg and Aschof, 1990) , and shifts to later in the year at higher latitudes. The relationship between hormone blood tests and fecundity is complex and affected by cultural factors. Nevertheless, the accumulated data suggests a winter/spring peak not only in effector hormones but also in the biological functions that they control.
The phases observed here, with spring delay in effector hormones and summer peaks of pituitary hormones, are not accounted for by classic descriptions of the hormonal axes. These phases can be explained by the action of the hormones as growth factors for their downstream glands. The gland masses change with the seasons, providing an inertia or memory that can entrain with the seasons. Such an internal 'glandmass' oscillator may have advantages by keeping track of the seasons, so that a cloudy day in summer is not interpreted as winter. Further tests of this model can measure gland volumes with seasons, and more specifically the total functional masses of the specific hormone-secreting cell types. This study used large-scale electronic medical records to obtain statistical power that allows a comprehensive view of hormone seasonality at the level of a few percent. To achieve this required filters to address ascertainment bias, including internal controls to remove records from people with illness or medications that affect each hormone, and to address circadian effects. Agreement with smaller-scale seasonality studies on cohorts of healthy individuals, where available, strengthens the confidence in this approach. This study raises the possibility of an internal seasonal clock in humans that provides a high endocrine set-point for reproduction, growth, metabolism and stress adaptation in winter-spring. It suggests that large-scale medical records can be used to test detailed mechanistic endocrine models and to provide a testing ground for dynamical physiological adaptations in humans. 
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Methods
Equations for the HPA model The classic HPA hormone cascade with the feedback by cortisol on upstream hormones (Ottesen et al., 2011) can described by:
(1) ), as is commonly assumed under physiological conditions (Andersen,Vinther & Ottesen, 2013; De Kloet et al. 1998) .
In this study we use the approach of Karin et al (Karin et al., 2020) , with maximal input at December 21. We used g=0.6, which best fits the latitude dependence of cortisol measurements in Fig 3F. Note that the value of g affects the amplitude but does not measurably affect the phases of the hormone dynamics (SI). We simulated 4 years of seasonal input to avoid transients. In order to simulate the response to a varying day-length input, we simulated the fast equations (Eqs. . Next, we used these quasi steady-state solutions in Eq 6,7 to find the seasonally varying values of A and P. To simulate morning cortisol blood tests, we computed the steady-state fast equation response to an input u=1, using the seasonally varying value of A and P. Simulations were done using Python.
Electronic Medical record data
The Clalit dataset contains the electronic health records (EHR) of 3.45 million individuals per year on average (Balicer and Afek, 2017). All data was anonymized by hashing of personal identifiers and addresses and randomization of dates by a random number of weeks uniformly sampled between 0 and 13 week for each patient and adding it to all dates in the patient diagnoses, laboratory and medication records. This approach maintained differential data analysis per patient. Diagnoses codes were acquired from both primary care and hospitalization records, and were mapped to the ICD9 coding system. Research was conducted under Clalit Helsinki Committee 0195-17-COM2.
Data processing
Clalit laboratory test records were studied in the age range of 20-50, with men and women analyzed separately. For tests with fewer than 10,000 records (ACTH, urinary
